Skip to main content
Equibles

Jessica Hopfield, Ph.D.

Board Member

Editas Medicine, Inc. (EDIT)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Jessica Hopfield, Ph.D.

Jessica Hopfield, Ph.D. is recorded as Board Member at Editas Medicine, Inc. (EDIT). Editas Medicine, Inc. reported in an 8-K filed June 2, 2025 that Jessica Hopfield, Ph.D. was appointed Class III director, effective May 29, 2025.

“The Company's stockholders elected Jessica Hopfield, Ph.D., and David Scadden, M.D., to serve as Class III directors until the 2028 Annual Meeting of Stockholders and until their successors are duly elected and qualified.”
Editas Medicine, Inc. Form 8-K, filed June 2, 2025 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Editas Medicine, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.